ADIPOQ and metabolic dysfunction-associated steatotic liver disease: It also exerted protective effects against the development of nonalcoholic fatty liver disease (NAFLD), partly by overexpression of adiponectin and reduction of inflammatory cytokine levels in ob/ob mice [10].